Relation of fasting plasma peptide YY to glucose metabolism and cardiovascular risk factors after restrictive bariatric surgery

Wiener Klinische Wochenschrift

Volumn 119, Issue 9-10, 2007, Pages 291-296

  Hanusch Enserer, Ursula ^a   Ghatei, Mohammed A ^b   Cauza, Edmund ^c   Bloom, Steven R ^b   Prager, Rudolf ^a   Roden, Michael ^d,e  

^a GENERAL HOSPITAL LINZ   (Austria)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c Wilhelminenspital ^*  (Austria)

^d HANUSCH HOSPITAL   (Austria)

^e Karl Landsteiner Institute for Endocrinology and Metabolism   (Austria)

Author keywords

Appetite; Gastric banding; Obesity; Peptide YY; Weight loss

Indexed keywords

CHOLESTEROL; GLUCOSE; INSULIN; PEPTIDE YY; TRIACYLGLYCEROL;

ADULT; ARTICLE; BARIATRIC SURGERY; BLOOD SAMPLING; BODY MASS; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GASTRIC BANDING; GLUCOSE METABOLISM; HORMONE DETERMINATION; HORMONE RELEASE; HUMAN; INSULIN RELEASE; INSULIN RESISTANCE; MALE; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PROTEIN BLOOD LEVEL; SURGICAL RISK; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT REDUCTION;

ADULT; ANALYSIS OF VARIANCE; CARDIOVASCULAR DISEASES; FASTING; FEMALE; FOLLOW-UP STUDIES; GASTROPLASTY; GLUCOSE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; OBESITY, MORBID; PEPTIDE YY; RISK FACTORS; TIME FACTORS; WEIGHT LOSS;

EID: 34347344954     PISSN: 00435325     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00508-007-0776-5     Document Type: Article

References (31)

1. Bray GA, Bellanger T (2006) Epidemiology, trends, and morbidities of obesity and the metabolic syndrome. Endocrine 29: 109-117
2. Porte D Jr, Seeley RJ, Woods SC, Baskin DG, Figlewicz DP, Schwartz MW (1998) Obesity, diabetes and the central nervous system. Diabetologia 41: 863-888
3. Margetic S, Gazzola C, Pegg GG, Hill RA (2002) Leptin: a review of its peripheral actions and interactions. Int J Obes 26: 1407-1433
4. Neary NM, Small CJ, Bloom SR (2003) Gut and mind. Gut 52: 918-921
5. Pappas TN, Debas HT, Goto Y, Taylor IL (1985) Peptide YY inhibits meal-stimulated pancreatic and gastric secretion. Am J Physiol 248: G118-G123
6. Batterham RL, Cohen MA, Ellis SM, Le Roux CW, Withers DJ, Frost GS, et al (2003) Inhibition of food intake in obese subjects by peptide YY3-36. NEJM 349: 941-948
7. Naslund E, Gryback P, Hellstrom PM, Jacobsson H, Holst JJ, Theodorrson E, et al (1997) Gastrointestinal hormones and gastric emptying 20 years after jejunoileal bypass for massive obesity. Int J Obes Relat Metab Disord 21: 387-392
8. Cummings DE, Shannon MH (2003) Ghrelin and gastric bypass: Is there a hormonal contribution to surgical weight loss? J Clin Endocrinol Metab 88: 2999-3002
9. Hanusch-Enserer U, Roden M (2005) News in gut-brain communication: a role of peptide YY (PYY) in human obesity and following bariatric surgery? Eur J CIin Invest 35: 425-430
10. Buchwald H, Williams SE (2004) Bariatric surgery worldwide 2003. Obes Surg 14: 1157-1164
11. Adrian TE, Sagor GR, Savage AP, Bacarese-Hamilton AJ, Hall GM, Bloom SR (1986) Peptide YY kinetics and effects of blood pressure and circulating pancreatic and gastrointestinal hormones and metabolites in man. J Clin Endocrinol Metab 63: 803-807
12. Nieuwenhuizen AG, Karlsson S, Fridolf T, Ahren B (1994) Mechanism underlying the insulinotropic effect of peptide YY in mouse pancreatic islets. Diabetologia 37: 871-878
13. Gastrointestinal surgery for severe obesity: national institutes of health consensus development conference statement (2002) Am J Clin Nutr 55: 615S-619S
14. Hanusch-Enserer U, Cauza E, Spak M, Endler G, Dunky A, Tura A, et al (2004) Improvement of insulin resistance and early atherosclerosis in patients after gastric banding. Obes Res 12: 284-291
15. Matthews DR, Hosker JP, Rudensky AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentration in man. Diabetologia 28: 412-419
16. Rabasa-Lhoret R, Bastard JP, Jan V, Ducluzeau PH, Andreelli F, Guebre F, Bruzeau J, et al (2003) Modified quantitative insulin sensitivity check index is better correlated to hyperinsulinemic glucose clamp than other fasting-based index of insulin sensitivity in different insulinresistant states. J Clin Endocrinol Metab 88: 4917-4923
17. Cummings DE, Overduin J, Foster-Schubert KE (2004) Gastric bypass for obesity: Mechanisms of weight loss and diabetes resolution. J Clin Endocrinol Metab 89: 2608-2615
18. Engl J, Hanusch-Enserer U, Prager R, Partsch J, Ebenbichler CF (2005) The metabolic syndrome: effects of a pronounced weight loss induced by bariatric surgery. Wien Klin Wochenschr 117: 243-254
19. Le Roux CW, Aylwin SJ, Batterham RL, Borg CM, Coyle F, Prasad V, et al (2006) Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters. Ann Surg 24: 108-114
20. Korner J, Leibel RL (2003) To eat or not to eat - How the gut talks to the brain. N Engl J Med 349: 926-928
21. Ballantyne GH (2006) Peptide YY (1-36) and Peptide YY (3-36) Part I. Distribution, release and actions. Obes Surg 16: 651-658
22. Ballantyne GH (2006) Peptide YY (1-36) and Peptide YY (3-36) Part II. Changes after gastrointestinal surgery and bariatric surgery. Obes Surg 16: 795-803
23. Pontiroli AE, Folli F, Paganelli M, Micheleletto G, Pizzocri P, Vedani P, et al (2005) Laparoscopic gastric banding prevents type 2 diabetes and arterial hypertension and induces their remission in morbid obesity. Diabetes Care 28: 2703-2709
24. Polyzogopoulou EV, Kalfarentzos F, Vagenaskis AG, Alexandrides TK (2003) Restoration of euglycemia and normal acute insulin response to glucose in obese subjects with type 2 diabetes mellitus following bariatric surgery. Diabetes 52: 1098-1103
25. Boey D, Lin S, Karl T, Baldock P, Lee N, Enriquez R, et al (2006) Peptide YY ablation in mice leads to the development of hyperinsulinemia and obesity. Diabetologia 49: 1360-1370
26. Koska J, DelParigi A, de Courten B, Weyer C, Tataranni PA (2004) Pancreatic polypeptide is involved in the regulation of body weight in Pima Indian male subjects. Diabetes 53: 3091-3096
27. Dubinion JH, Mi Z, Zhu C, Gao L, Jackson EK (2006) Pancreatic-fold polypeptide receptors and angiotensin Iiinduced renal vasoconstriction. Hypertension 47: 545-551
28. Le Roux CW, Ghatei MA, Gibbs JSR, Bloom SR (2005) The putative satiety hormone PYY is raised in cardiac cachexia associated with pulmonary hypertension. Heart 91: 241-242
29. Lugari R, David S, Dall'Argine P, Nicolotti V, Parmeggiani A, Gnudi A, et al (1985) Human pancreatic polypeptide and somatostatin in chronic renal failure. Proc Eur Dial Transplant Assoc Eur Ren Assoc 21: 614-617
30. Hegbrant J, Thysell H, Ekman R (1991) Plasma levels of gastrointestinal regulatory peptides in patients receiving maintenance hemodialysis. Scand J Gastroenterol 26: 599-604
31. Allen CJ, Ghilardi JR, Vigna SR, Mannon PJ, Taylor IL, McVey DC, et al (1993) Neuropeptide Y/peptide YY receptor binding sites in the heart: localization and pharmacological characterization. Neuroscience 53: 889-898